In the former bucket, Medtronic struggled with supply shortages in surgical innovations, delayed U.S. regulatory approval of the 780g insulin pump, and battery replacement headwinds in ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...

However, Medtronic (MDT) shares ticked higher premarket ... Thanks to the newly launched MiniMed 780G insulin pump, MDT's diabetes sales in Q4 grew ~11% YoY to $660M, compared to $650M in the ...

G7 continuous glucose monitoring device (780G is also a "CGM"), and Abbott Laboratories (ABT) Freestyle Libre. Medtronic also has market leadership in the automated insulin pump markets.

Medtronic's business spans several therapeutic ... A few years ago, it launched the MiniMed 780G, an innovative insulin pump that can automatically adjust insulin delivery based on patients ...